Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Frontiers in Endocrinology|October 3, 2022
Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADSLorenzo Scappaticcio, Pierpaolo Trimboli, Sergio Iorio, et al.Ebiomedicine|February 15, 2020
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytesMarica Meroni, Paola Dongiovanni, Miriam Longo, et al.JHEP Reports : Innovation in Hepatology|October 27, 2025
Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLDMiriam Longo, Erika Paolini, Marica Meroni, et al.International Journal of Molecular Sciences|August 12, 2023
Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent PorphyriaMiriam Longo, Daniel Jericó, Karol M Córdoba, et al.Cellular and Molecular Gastroenterology and Hepatology|November 25, 2021
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro ModelsMiriam Longo, Marica Meroni, Erika Paolini, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2026
Single Cell Analysis Reveals the Presence of Novel Intermediate Cells in Both Mice and Patients With Severe MASLDMarica Meroni, Paride Pelucchi, Erika Paolini, et al.Journal of Lipid Research|March 29, 2019
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patientsPaola Dongiovanni, Marica Meroni, Guido Baselli, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2021
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver diseaseStefania Grimaudo, Paola Dongiovanni, Jussi Pihlajamäki, et al.Journal of Hepatology|October 27, 2023
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver diseaseFederico Salomone, Rosaria Maria Pipitone, Miriam Longo, et al.Cell Metabolism|February 27, 2025
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitisFanglin Ma, Miriam Longo, Marica Meroni, et al.Pageof 13